China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Response-guided neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133441
Registration Time: 2026/09/28
Type: Interventional study
Primary Sponsor: Shanghai East Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345392
Published by HT Digital Content Services with permission from Health Daily Digest....